Free Trial

Perrigo Sees Unusually Large Options Volume (NYSE:PRGO)

Perrigo logo with Medical background

Perrigo Company plc (NYSE:PRGO - Get Free Report) was the target of some unusual options trading on Tuesday. Traders acquired 11,385 call options on the company. This represents an increase of approximately 850% compared to the average volume of 1,198 call options.

Wall Street Analyst Weigh In

PRGO has been the topic of several analyst reports. StockNews.com lowered Perrigo from a "buy" rating to a "hold" rating in a report on Saturday. Argus lowered Perrigo from a "buy" rating to a "hold" rating in a research note on Tuesday. Piper Sandler lowered Perrigo from an "overweight" rating to a "neutral" rating and reduced their price objective for the company from $34.00 to $27.00 in a research note on Monday, January 6th. Jefferies Financial Group reaffirmed a "hold" rating and issued a $30.00 price objective (down from $50.00) on shares of Perrigo in a research note on Monday, September 23rd. Finally, Canaccord Genuity Group reaffirmed a "buy" rating and issued a $42.00 price objective on shares of Perrigo in a research note on Monday, September 30th. Four investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $35.00.

Read Our Latest Stock Analysis on PRGO

Perrigo Trading Down 3.2 %

Shares of PRGO stock traded down $0.77 during mid-day trading on Tuesday, reaching $23.57. 1,794,254 shares of the stock traded hands, compared to its average volume of 1,585,242. The stock's fifty day simple moving average is $26.71 and its two-hundred day simple moving average is $26.80. Perrigo has a 1-year low of $23.14 and a 1-year high of $33.96. The company has a market cap of $3.22 billion, a price-to-earnings ratio of -20.15 and a beta of 0.53. The company has a quick ratio of 1.77, a current ratio of 2.56 and a debt-to-equity ratio of 0.94.

Perrigo (NYSE:PRGO - Get Free Report) last announced its quarterly earnings results on Wednesday, November 6th. The company reported $0.81 EPS for the quarter, meeting analysts' consensus estimates of $0.81. Perrigo had a positive return on equity of 7.38% and a negative net margin of 3.64%. The firm had revenue of $1.09 billion for the quarter, compared to analyst estimates of $1.12 billion. During the same period last year, the firm posted $0.64 earnings per share. The business's revenue for the quarter was down 3.2% on a year-over-year basis. On average, research analysts anticipate that Perrigo will post 2.56 EPS for the current fiscal year.

Perrigo Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Friday, November 29th were given a dividend of $0.276 per share. The ex-dividend date was Friday, November 29th. This represents a $1.10 dividend on an annualized basis and a dividend yield of 4.68%. Perrigo's dividend payout ratio (DPR) is -94.02%.

Insider Activity at Perrigo

In other news, Director Jeffrey B. Kindler sold 17,598 shares of the stock in a transaction on Monday, December 9th. The stock was sold at an average price of $28.27, for a total transaction of $497,495.46. Following the sale, the director now directly owns 5,409 shares of the company's stock, valued at approximately $152,912.43. This represents a 76.49 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.70% of the stock is owned by company insiders.

Hedge Funds Weigh In On Perrigo

A number of hedge funds have recently made changes to their positions in PRGO. Texas Permanent School Fund Corp raised its position in shares of Perrigo by 1.2% during the second quarter. Texas Permanent School Fund Corp now owns 119,298 shares of the company's stock worth $3,064,000 after acquiring an additional 1,357 shares during the last quarter. American Century Companies Inc. raised its position in shares of Perrigo by 13.7% during the second quarter. American Century Companies Inc. now owns 24,334 shares of the company's stock worth $625,000 after acquiring an additional 2,929 shares during the last quarter. Dimensional Fund Advisors LP raised its position in shares of Perrigo by 3.6% during the second quarter. Dimensional Fund Advisors LP now owns 7,162,656 shares of the company's stock worth $183,935,000 after acquiring an additional 249,640 shares during the last quarter. Meiji Yasuda Asset Management Co Ltd. raised its position in shares of Perrigo by 4.2% during the second quarter. Meiji Yasuda Asset Management Co Ltd. now owns 301,570 shares of the company's stock worth $7,744,000 after acquiring an additional 12,254 shares during the last quarter. Finally, Amalgamated Bank raised its position in shares of Perrigo by 3.3% during the second quarter. Amalgamated Bank now owns 85,350 shares of the company's stock worth $2,192,000 after acquiring an additional 2,752 shares during the last quarter. 95.91% of the stock is currently owned by institutional investors.

About Perrigo

(Get Free Report)

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.

Further Reading

Should You Invest $1,000 in Perrigo Right Now?

Before you consider Perrigo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Perrigo wasn't on the list.

While Perrigo currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Oracle’s Cloud Shift Pays Off: Will Momentum Continue?

Oracle’s Cloud Shift Pays Off: Will Momentum Continue?

Analysts boosting their targets. Find out how Oracle’s cloud push is reshaping its business and driving new growth opportunities.

Recent Videos

Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025
Investing in Quantum Computing: Is Rigetti the Stock to Watch?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines